Niki BioSolutions, Inc. (NIKI) Earnings History
Net Loss9 years of earnings data (2017–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Niki BioSolutions, Inc. (NIKI) Earnings Overview
As of November 8, 2026, Niki BioSolutions, Inc. (NIKI) reported trailing twelve-month net income of -$1M, reflecting +75.6% year-over-year growth. The company earned $-19.00 per diluted share over the past four quarters.
Looking at the long-term picture, NIKI's historical earnings data spans multiple years. The company achieved its highest annual net income of $7M in fiscal 2020.
Niki BioSolutions, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including ZLAB (-$198M net income, -38.1% margin), NVAX (-$77M net income, 39.2% margin), AEYE (-$3M net income, -7.6% margin), NIKI has comparable earnings metrics. Compare NIKI vs ZLAB →
NIKI Earnings vs Peers
Earnings metrics vs comparable public companies
NIKI Historical Earnings Data (2017–2025)
9 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$1M | +68.1% | -$2M | $-19.00 | - | - |
| 2024 | -$4M | -51.1% | -$4M | $-78.00 | - | - |
| 2023 | -$3M | +71.2% | -$11M | $-62.00 | -654.9% | -2457.5% |
| 2022 | -$10M | +60.9% | -$18M | $-275.00 | -756.2% | -1351.0% |
| 2021 | -$25M | -454.4% | -$19M | $-715.00 | -1624.4% | -1245.6% |
| 2020 | $7M | +137.8% | -$20M | $200.00 | 775.3% | -2182.6% |
| 2019 | -$19M | -26.0% | -$18M | $-640.00 | -3491.8% | -3400.4% |
| 2018 | -$15M | -482.3% | -$10M | $-531.00 | -3868.0% | -2693.4% |
| 2017 | -$3M | - | -$6M | $-85.00 | - | - |
Download Data
Export NIKI earnings history in CSV or JSON format
Free sign-in required to download data
NIKI Chart Terminal
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
Live Breakouts Feed
High-probability breakout stocks crossing their pivot across 5 pattern engines.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
9+ years return with dividends reinvested.
Peer Comparison
Compare growth, multiples, and margins vs sector.
NIKI — Frequently Asked Questions
Quick answers to the most common questions about buying NIKI stock.
What is NIKI earnings per share (EPS)?
NIKI trailing twelve-month (TTM) diluted EPS is $-19.00, reflecting +75.6% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2017 to 2025 is available in the table on this page.
What is Niki BioSolutions, Inc.'s net income?
Niki BioSolutions, Inc. (NIKI) trailing twelve-month net income is $-1M as of 2025. Earnings grew +75.6% year-over-year.
Is NIKI profitable?
NIKI is not currently profitable on a TTM basis, reporting a net loss of $-1M. Net margin is N/A. Investors should monitor for a return to profitability.
What is NIKI's earnings growth rate?
NIKI compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2017 to 2025.
What are NIKI's profit margins?
Niki BioSolutions, Inc. net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is -10.7%.
Is NIKI growing earnings?
Yes, NIKI earnings are accelerating — EPS growth of +75.6% exceeds the 5-year CAGR of N/A. TTM net income reached $-1M. Earnings momentum is strengthening.
What was NIKI's best earnings year?
Niki BioSolutions, Inc.'s highest annual net income on record is $7M, achieved in fiscal year 2020. Earnings history on this page spans 2017 to 2025 and includes all annual and quarterly figures.
What were NIKI's earnings last quarter?
NIKI's most recent reported quarter was Q4 2025. Net income was $-307495.00 with diluted EPS of $-4.20. For a full breakdown of all quarters, see the quarterly earnings table on this page.